Evaluation of trivalent, live, cold-adapted (CAIV-T) and inactivated (TIV) influenza vaccines in prevention of virus infection and illness following challenge of adults with wild-type influenza A (H1N1), A (H3N2), and B viruses

By Treanor J.J.   Kotloff K.   Betts R.F.   Belshe R.   Newman F.   Iacuzio D.   Wittes J.   Bryant M.  

Vaccine, Vol. 18, Iss. 9, 1999-12 ,pp. : 899-906

Elsevier

Access to resources Recommend Favorite

Preparation and characterisation of attenuated cold-adapted influenza A reassortants derived from the A/Leningrad/134/17/57 donor strain

By Wareing M.D.   Marsh G.A.   Tannock G.A.  

Vaccine, Vol. 20, Iss. 16, 2002-05 ,pp. : 2082-2090

Elsevier

Access to resources Recommend Favorite

Cold-adapted live influenza vaccine versus inactivated vaccine: systemic vaccine reactions, local and systemic antibody response, and vaccine efficacy - A meta-analysis

By Beyer W.E.P.   Palache A.M.   de Jong J.C.   Osterhaus A.D.M.E.  

Vaccine, Vol. 20, Iss. 9, 2002-01 ,pp. : 1340-1353

Elsevier

Access to resources Recommend Favorite

Route of administration is the prime determinant of IgA and IgG2a responses in the respiratory tract of mice to the cold-adapted live attenuated influenza A donor strain A/Leningrad/134/17/57

By Wareing M.D.   Tannock G.A.  

Vaccine, Vol. 21, Iss. 23, 2003-07 ,pp. : 3097-3100

Elsevier

Access to resources Recommend Favorite

Mutant Escherichia coli heat-labile enterotoxin [LT(R192G)] enhances protective humoral and cellular immune responses to orally administered inactivated influenza vaccine

By Lu X.   Clements J.D.   Katz J.M.  

Vaccine, Vol. 20, Iss. 7, 2002-01 ,pp. : 1019-1029

Elsevier

Access to resources Recommend Favorite